News24.com | 'Blow-out' smoker's lung treatment data boosts drugmaker Sanofi

Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung", potentially adding billions to the French drugmaker's growth prospects, but also underscoring a heavy reliance on its bestseller.